40 /100
MEDIUM RISK
Score updated Jul 14, 2026

ERAS — Erasca, Inc. Dilution Risk Tracker

Track ERAS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ERAS — Get alerts when the score changes →

As of July 14, 2026, Erasca, Inc. (ERAS) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. Erasca, Inc. has a market capitalization of $3.99B, 310.98M shares outstanding, 226 institutional holders tracked. Key dilution vectors include ATM program capacity of $200.00M, approximately 10 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
37
💰 Cash Runway
65
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
16%
💰 Capital Raise 33%
• Under 12 months cash (10mo)
• Active ATM program with $200M remaining capacity
🔔 Track ERAS — Get forecast alerts →

💹 Market Data

Market Cap$3.99B
Shares Outstanding310.98M
Float207.89M
Cash$101.24M
Debt$45.95M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 36.7% shares (2026Q1 vs prior)
226 institutional holders · 312.71M shares
#1 Frazier Life Sciences Management, L.P. 24.68M shares
#2 Vivo Capital, LLC 24.30M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 22.50M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest32.32M
Days to Cover4.5
% of Float15.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Mar 06, 2026
4 INSIDER TRANSACTION Jan 30, 2026
4 INSIDER TRANSACTION Jan 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ERAS Shareholders

Erasca, Inc. (ERAS) has a DilutionScore of 40/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

ERAS has an active ATM (at-the-market) program with $200.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. Cash runway is a key watch item: ERAS has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ERAS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ERAS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track ERAS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ERAS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ERAS
📊 ERAS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ERAS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.